tweenvest

NOVAST Laboratories, Limited (SZSE: 301569)

Health Care · Pharmaceuticals · CN

CN¥16.73

-2.96% today · -52.4% 1Y

Public summary
A free snapshot of NOVAST Laboratories, Limited, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

NOVAST Laboratories, Limited (SZSE: 301569) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.24B and employs 697 people.

Over the last twelve months the share price has lost 52.4%, trading between 16.73 and 42.15.

Tweenvest scores NOVAST Laboratories, Limited across four factors: quality 83/100, value 4/100, growth 52/100. Its strongest factor is quality.

301569 price history

Oct 16, 2026 · 25.17Weekly closes 16.73 – 25.17Nov 17, 2026 · 16.73

Key figures

Market cap
$2.24B
Revenue (TTM)
$150.54M
P/E
40.88
EPS
0.27
Dividend yield
—
Beta (5Y)
—
52-week high
CN¥42.15
52-week low
CN¥16.73
Avg volume (3M)
—
Shares outstanding
891.60M
Employees
697
Next earnings
—

About NOVAST Laboratories, Limited

NOVAST Laboratories, Limited develops, manufactures, and sells prescription drug formulations. The company produces controlled-release formulations, including extended-release and sustained-release tablets and capsules, as well as low-dose drug formulations. Its products include Metoprolol Succinate Extended-Release Tablets, Nifedipine Extended-Release Tablets, Diltiazem Hydrochloride Extended-Release Capsules, Metformin Hydrochloride Sustained-Release Tablets, Levonorgestrel Tablets, Memantine Hydrochloride Extended-Release Capsules, Quetiapine Fumarate Sustained-Release Tablets, and Tolterodine tablets for urinary frequency and urgency. The company also develops a digestive-system extended-release tablet designated DG-062. Additionally, the company provides formulation contract research organization (CRO) services, including prescription process development and regulatory filing and clinical support services for pharmaceutical companies and research institutions, as well as outsourced CRO and contract manufacturing organization (CMO) services for innovative drugs. NOVAST Laboratories, Limited was incorporated in 2005 and is based in Nantong, China.

ISIN
CNE1000080W6
Founded
2005
Listed since
Oct 15, 2026
Exchange
Shenzhen Stock Exchange
Currency
CNY
CompanyMarket capPriceDay
Aether Industries LimitedNSEI: AETHER$2.36BRs1,677.20-0.72%
China Resources Jiangzhong Pharmaceutical Co.,LtdSHSE: 600750$2.30BCN¥24.40+2.18%
Shandong Buchang Pharmaceuticals Co., Ltd.SHSE: 603858$2.28BCN¥14.65-1.61%
Pharvaris N.V.NasdaqGS: PHVS$2.28B$32.44-2.76%
Zhejiang Hisun Pharmaceutical Co., Ltd.SHSE: 600267$2.23BCN¥12.87-3.52%
Tonghua Dongbao Pharmaceutical Co., Ltd.SHSE: 600867$2.23BCN¥7.60-0.65%
Perrigo Company plcNYSE: PRGO$2.23B$16.04-5.31%
Jamjoom Pharmaceuticals Factory CompanySASE: 4015$2.22BSR119.20+1.79%

Browse every Pharmaceuticals company →